BAX vs PATH · rev $2.75B vs P/E 19, rev $1.61B
Baxter International Inc (BAX) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Baxter International Inc (BAX) is a medical instruments & supplies company listed on NYSE.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported BAX revenue for 2024-12-31 was $2.75B. Net income was -$510.0M. Revenue was up 2.0% from 2024-09-30 to 2024-12-31. BAX currently screens at market cap $10.01B.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
BAX currently screens at market cap $10.01B. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the BAX and PATH stock pages for the full models.
Not investment advice.